You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mast cell leukemia (MCL)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Semarang (AV-COVID-19, GM-CSF)

Completed
  • COVID-19
  • AV-COVID-19
  • GM-CSF
  • Semarang, Jawa Tengah, Indonesia
    Rumah Sakit Umum Pusat Dr. Kariadi
Dec 14, 2021

NSCLC Trial in Worldwide (Osimertinib, Pemetrexed/Carboplatin, Pemetrexed/Cisplatin)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Bellflower, California
  • +154 more
Dec 23, 2022

Acute Myeloid Leukaemia, Myelodysplasia Trial in Birmingham (Vyxeos, Fludarabine, Busulphan)

Recruiting
  • Acute Myeloid Leukaemia
  • Myelodysplasia
  • Birmingham, United Kingdom
    Queen Elizabeth Hospital
Oct 14, 2021

State and Quality of Life in HIV- Infected Upper Egypt

Recruiting
  • Hiv
  • questionnare
  • Assiut, Egypt
    Shimaa
Apr 12, 2022

Renal Cell Carcinoma, Nonclear Cell, Temsirolimus Resistance Trial in Seoul (Axitinib)

Completed
  • Renal Cell Carcinoma
  • +2 more
  • Seoul, Korea, Republic of
    Seou National University Hospital
Dec 4, 2020

Gastro-Intestinal Acute GVHD (GI-aGVHD) Trial in Cleveland (Fecal Microbiota Transplantation (FMT))

Withdrawn
  • Gastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD)
  • Fecal Microbiota Transplantation (FMT)
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Jul 1, 2022

Multiple Myeloma, Renal Failure Trial in Worldwide (Data collection)

Active, not recruiting
  • Multiple Myeloma
  • Renal Failure
  • Data collection
  • Alger, Algeria
  • +32 more
Feb 7, 2022

Acute Myeloid Leukemia (AML) Trial in Tianjin (CT053PTSA)

Terminated
  • Acute Myeloid Leukemia (AML)
  • Tianjin, China
    Hospital of Blood Disease, Chinese Academy of Medical Sciences
Mar 22, 2021

Recurrent Glioblastoma Trial in Beijing (Combined stereotactic radiosurgery and enhanced immunotherapy)

Recruiting
  • Recurrent Glioblastoma
  • Combined stereotactic radiosurgery and enhanced immunotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Nov 16, 2021

Stereotactic Radiosurgery Combination With Anlotinib for Limited

Completed
  • Stereotactic Body Radiation Therapy
  • Beijing, Beijing, China
    Department of Radiation Oncology Cancer Center, Peking Universit
May 31, 2021

NSCLC Trial in United States (Ixabepilone, Carboplatin, Bevacizumab)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Fort Myers, Florida
  • +12 more
Dec 13, 2021

Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,

Recruiting
  • Non-Small Cell Lung Carcinoma (NSCLC)
  • +2 more
  • Selinexor 100 mg
  • +6 more
  • Ashdod, Israel
  • +10 more
Jan 30, 2023

Influenza, Human, Immune Response Trial in Pittsburgh (FluMist live attenuated influenza vaccine, Flucelvax inactivated

Completed
Has Results
  • Influenza, Human
  • Immune Response
  • FluMist live attenuated influenza vaccine
  • Flucelvax inactivated influenza vaccine
  • Pittsburgh, Pennsylvania
  • +1 more
Sep 17, 2021

Sickle Cell Trait Trial in Saint Louis (Exercise)

Recruiting
  • Sickle Cell Trait
  • Exercise
  • Saint Louis, Missouri
    Saint Louis University
Jan 11, 2022

Head Neck Cancer, Squamous Cell Carcinoma Trial in Changsha (PD-1 inhibitor, Albumin Paclitaxel, Cisplatin)

Recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma
  • PD-1 inhibitor
  • +2 more
  • Changsha, Hunan, China
    Hunan cancer Hospital
Jun 9, 2021

DLBCL Trial in Cleveland (ME-401, Rituximab, Cyclophosphamide)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Feb 2, 2022

Severe COVID-19 Disease Trial in Hackensack (RAPA-501-Allo off-the-shelf Therapy of COVID-19, Placebo)

Terminated
  • Severe COVID-19 Disease
  • RAPA-501-Allo off-the-shelf Therapy of COVID-19
  • Placebo
  • Hackensack, New Jersey
    Hackensack University Medical Center
Nov 3, 2021

NSCLC Trial in Chongqing (procedure, drug, radiation)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • bronchial artery interventional therapy
  • +3 more
  • Chongqing, Chongqing, China
    Daping Hospital, Third Military Medical University
May 27, 2023

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma Trial

Active, not recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 3, 2022

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in San Francisco (drug,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +9 more
  • San Francisco, California
    University of California, San Francisco
Feb 17, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Brentuximab Vedotin, Cyclosporine, Pharmacokinetic

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin, Docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • Los Angeles, California
  • +212 more
Jan 26, 2023

Noninvasive vs. Invasive Lung Evaluation

Completed
  • Non-Small Cell Lung Cancer
  • Guardant360
  • (no location specified)
Apr 29, 2021

Hematologic Diseases Trial in Istanbul (music therapy)

Completed
  • Hematologic Diseases
  • musıc therapy
  • Istanbul, Turkey
  • +1 more
Aug 19, 2021

HIV-1 Infection Trial in United States (Emtricitabine/rilpivirine/tenofovir disoproxil fumarate)

Completed
Has Results
  • HIV-1 Infection
  • Emtricitabine/rilpivirine/tenofovir disoproxil fumarate
  • Birmingham, Alabama
  • +18 more
Jul 31, 2021